In this work, we evaluated the effects of Psidium cattleianum (Red Type) (PcRT) fruit extract on metabolic, behavioral, and neurochemical parameters in rats fed with a highly palatable diet (HPD) consisted of sucrose (65% carbohydrates being 34% from condensed milk, 8% from sucrose and 23% from starch, 25% protein and 10% fat). Animals were divided into 4 groups: standard chow, standard chow + PcRT extract (200 mg/Kg/day by gavage), HPD, HPD + extract. The animals were treated for 150 days. Concerning chemical profiling, LC/PDA/MS/MS analysis revealed cyanidin-3-O-glucoside as the only anthocyanin in the PcRT extract. Our results showed that the animals exposed to HPD presented glucose intolerance, increased weight gain and visceral fat, as well as higher serum levels of glucose, triacylglycerol, total cholesterol, LDL-cholesterol and interleukin-6. These alterations were prevented by PcRT. In addition, HPD caused an increase in immobility time in a forced swimming test and the fruit extract prevented this alteration, indicating an antidepressant-like effect. PcRT treatment also prevented increased acetylcholinesterase activity in the prefrontal cortex caused by HPD consumption. Moreover, PcRT extract was able to restore Ca 2+ -ATPase activity in the prefrontal cortex, hippocampus, and striatum, as well as Na + ,K + -ATPase activity in the prefrontal cortex and hippocampus. PcRT treatment decreased thiobarbituric acid-reactive substances, nitrite, and reactive oxygen species levels and prevented the reduction of superoxide dismutase activity in all cerebral structures of the HPD group. Additionally, HPD decreased catalase in the hippocampus and striatum. However, the extract prevented this change in the hippocampus. Our results showed that this berry extract has antihyperglycemic and antihyperlipidemic effects, and neuroprotective properties, proving to be a potential therapeutic agent for individuals with metabolic syndrome.
Introduction
Metabolic syndrome (MetS) is characterized by a combination of cardiovascular risk factors including hyperglycemia, dyslipidemia, and insulin resistance (IR) (Auberval et al. 2017 ). In addition, obesity has also been involved in this syndrome and may contribute to pro-inflammatory and oxidant effects (Wellen and Thompson 2010; Auberval et al. 2017) . It has been shown that highly palatable diet (HPD) stimulates food intake and, consequently, promotes alterations in homeostasis related to utilization of glucose, and may lead to hyperglycemia, IR, and fatty acid oxidation (Erlanson-Albertsson 2005) .
In normal metabolism, there is a balance between oxidants and antioxidants in order to maintain redox homeostasis. However, in increased energy intake, an imbalance can occur, leading to overproduction of reactive oxygen species (ROS) and reduction of antioxidant defenses. It can result in oxidative stress, which may contribute to the development of ailments such as coronary heart disease, neurological disorders, diabetes and MetS (Paredes-Lopez et al. 2010; Da Silva et al. 2014) .
Evidence suggests that inflammation as well oxidative stress present in MetS can be related to the development of neuropsychiatric disorders such as depression, anxiety, schizophrenia and bipolar disorder, supporting the importance of the brain in the physiopathology of peripheral energy balance and glucose homeostasis (Farooqui et al. 2012; Zhang and Yao 2013; Gancheva et al. 2017; Oliveira et al. 2017a, b) . Furthermore, increases in ROS can lead to inhibition of the enzyme Na -ATPase are transmembrane proteins, known not only for the function of ion pump, but also because they are important for cellular and synaptic functions (Kirshenbaum et al. 2011; Carvalho et al. 2015; Srikanthan et al. 2016 ). In addition, Srikanthan and collaborators (2016) showed that the activation signaling cascade of Na + ,K + -ATPase contributes to the worsening of obesity, dyslipidemia, diabetes, and atherosclerosis.
Acetylcholinesterase (AChE) is an enzyme responsible for the hydrolysis of the neurotransmitter acetylcholine (ACh) in cholinergic synapses (Zarros et al. 2009; Kade and Rocha 2013) . The increase in the activity of this enzyme leads to a reduction in the efficiency of cholinergic neurotransmission due to a decrease in ACh levels, contributing to cognitive and neuropsychiatric disorders (Kade and Rocha 2013) . In addition, an increase in AChE activity has been observed in animal models of diabetes and MetS, and oxidative stress seems to be involved in this increase, given that antioxidant therapies contribute to the maintenance of adequate levels of ACh in the synaptic cleft (Melo et al. 2003; Zarros et al. 2009; Kade and Rocha 2013; Oliveira et al. 2017b ).
Given the variety of factors involved in the physiopathology of MetS and the use of multiple therapies, often with adverse effects, alternative therapies have been sought to prevent or control this syndrome. It has been shown that natural products have several bioactive compounds that exhibit antioxidant actions and may contribute to the prevention of diseases such as MetS, diabetes, and neuropsychiatric disorders (Devalaraja et al. 2011) . Complementarily, biological activity seems be result of the combination of several compounds and thus the isolation process may lead to its loss or reduction (Williamson 2001; Raskin and Ripoll 2004; Cravotto et al. 2010; Carmona and Pereira 2013) .
Psidium cattleianum Sabine Red Type (Myrtaceae) is a native fruit of Brazil that has a wide variety of uses in popular medicine, and has hypoglycemic, antibacterial, anti-inflammatory, analgesic, and central nervous system activities (Mattos Jr 1989; Inhwan et al. 2012) . Additionally, these red fruits have a high content of phytochemicals such as, anthocyanins, flavonoids and phenolic acids, which also provide antioxidant properties that, can minimize oxidative damage caused by ROS (Biegelmeyer et al. 2011; Silva et al. 2014) .
Studies carried out by our research group in order to seek new strategies for the control and prevention of MetS have already demonstrated that red fruit extracts such as Eugenia uniflora and Vaccinium virgatum present anti-hyperglycemic, anti-hyperlipidemic, and neuroprotective activities (Oliveira et al. 2017a, b) . In this sense, the objective of this study was to investigate whether P. cattleianum (PcRT) fruit extract could protect rats fed with a HPD against metabolic, neurochemical, and behavioral alterations observed in MetS.
Materials and methods

Phytochemicals Extraction
PcRT fruits were harvested in an orchard belonging to Embrapa Clima Temperado (Brazilian Agricultural Research Corporation) Pelotas/RS, Brazil. The extracts were prepared according to Bordignon et al. (2009) . Unprocessed frozen PcRT fruits (30 g) were sonicated for 30 min at 25°C in 90 mL 70:30 v/v ethanol-water. The pH of the solution was adjusted to 1.0. After this, the crude extracts were filtered, the ethanol was evaporated under reduced pressure and the remaining aqueous solution was lyophilized yielding the test samples.
Total phenolic, flavonoid and anthocyanin contents
The total phenolic content was determined according to Singleton et al. (1999) , and expressed as milligrams of gallic acid per 1 g of dried extract. The total flavonoid content was measured as described by Miliauskas et al. (2004) and results were expressed as milligrams of gallic acid per 1 g of dried extract. Anthocyanins were quantified as described by Lee et al. (2005) and reported as milligrams of cyanidin-3-glucoside per 1 g of dried extract. All data were expressed as means ± SD and analyses were performed in triplicate.
Identification of anthocyanins by LC/PDA/MS/MS
Anthocyanins were identified using an Acquity-UPLC™ coupled to a photodiode array detector (PDA) and to a highresolution mass spectrometer (Xevo® G2 QTof model -WATERS® , USA). Chromatographic separation was performed using a C18 chromatography column (Synergi™-Phenomenex®, USA) 4 μm, 150 × 2.0 mm at 40°C, and the injection volume was 5 μL. The elution was carried out using an aqueous solution of formic acid 2% (solvent A) and acetonitrile with 1% of formic acid (solvent B). The method used a linear gradient at constant flow rate (0.4 mL.min
−1
). The total time of analysis was 34 min according to the following conditions: 0-10 min, 5-12% B; 10-29 min, 12-18% B; 29-33 min, 18% B; 33-34 min, 5% B. Detection was performed at 520 nm, and the range of spectral scanning in the visible region was 450-600 nm (PDA). Mass spectrometry was carried out with an electrospray ionization source (ESI) set on negative ion mode, capillary voltage 1.0 kV, source block temperature 120°C, desolvation temperature 600°C; nebulizer nitrogen flow rate 80 L h , and cone voltage, 40 V, controlled by MassLynx v.4.1 software for data acquisition and processing. The mass scanning ranged from 200 to 1500 m/z with a scan time of 0.5 s. MS/MS analysis was performed using a collision energy ramp (10-30 eV); and with argon as the collision gas. All analyses were performed in triplicate.
Animal and extract treatments
Wistar rats aged 21 days and maintained at 21-25°C with free access to water and food, under a 12:12 h light:dark cycle (lights on at 7:00 a.m.) were used throughout this study. The animals were housed in groups of 3-4 per cage.
Forty male rats were divided into four groups: (1) standard chow group (SC) + vehicle, which received standard laboratory rat chow (50% carbohydrate from starch, 22% protein and 4% fat) and water; (2) SC + PcRT, with standard laboratory rat chow and PcRT; (3) HPD + vehicle, which received a diet consisted of sucrose (65% carbohydrates being 34% from condensed milk, 8% from sucrose and 23% from starch, 25% protein and 10% fat) and water (4) HPD + PcRT. The treatments lasted 150 days and the dose of extract administered was 200 mg/Kg/day by gavage. The animal model of MetS and the dose of PcRT extract were based on Oliveira et al. (2017a, b) . The experiments were performed after approval by the Ethics Committee of the Institution (CEEA n°9125) and all efforts were made to minimize animal suffering.
Body weight gain and food intake
Changes in body weight and food intake patterns of rats were measured throughout the experimental period. The weight of each rat was recorded on day 0 and at weekly intervals throughout the course of the study. The quantity of food consumed by each group was recorded weekly, and the food consumption per rat was calculated for each group.
Sample collection and biochemical assay
After 150 days of food and extract administration, 24 h after last behavioral test and after 6 h of fasting the animals were euthanized by decapitation without anesthesia. At euthanasia, visceral fat was weighed and the blood collected. Serum was obtained by centrifugation at 800 x g (4°C) for 15 min. Prefrontal cortex (PFC), hippocampus (HP), and striatum (ST) were separated and stored at −80°C for subsequent biochemical analyses.
Glucose tolerance test
The glucose tolerance test was performed 2 days before the euthanasia. Rats were injected intraperitoneally with 50% glucose solution to achieve 2 mg/g of body weight. The glucose levels for all the groups were estimated using a glucometer (AccuChek Active, Roche Diagnostics®, USA) at 30, 60, and 120 min after the glucose injection by a small tail puncture to collect blood.
Serum biochemical parameters
Measurements of serum glucose, total cholesterol, cholesterol-LDL, cholesterol-HDL, triacylglycerol (TAG), urea, uric acid, and alanine aminotransferase (ALT) levels were determined using commercially available diagnostic kits supplied by Labtest® (Labtest, MG, Brazil). Interleukin-6 (IL-6) quantity was assessed by ELISA using commercial kits (R&D Systems) according to the manufacturer's instructions.
Behavioral analysis
Open-field test
Ambulatory behavior was assessed in an open-field test as previously described by Gazal et al. (2015) . The experimental apparatus consisted of a box measuring 40 × 60 × 50 cm. with the floor of the arena divided into 12 equal squares and placed in a sound-free room. Animals were placed in the rear left square and left to freely explore for 5 min during which time the number of squares crossed with all paws (crossing) was counted.
Forced swimming test (FST)
Depressive-like behavior was evaluated by the total duration of immobility in the forced swimming test, as previously described Huynh et al. (2011) . Rats were individually forced to swim in an open cylindrical container 45 cm high and 20 cm in diameter and depth of 30 cm, with water at 22 ± 1°C and the total duration of immobility during a 5 min period was scored: rats were judged to be immobile when they ceased struggling and remained floating motionless in the water, making only those movements necessary to keep the head above water.
Tissue preparation
Prefrontal cortex (PFC), hippocampus (HP), and striatum (ST) were homogenized in sodium phosphate buffer, pH 7.4, containing KCl. The homogenates were centrifuged at 800×g for 10 min at 4°C and the supernatant was used for neurochemical analyses. Protein concentration was determined by the method of Lowry et al. (1951) or Bradford (1976) .
Acetylcholinesterase (AChE) activity
AChE activity was determined as described in the colorimetric method of Ellman et al. (1961) with modifications and expressed as μmol AcSCh/h/mg of protein. -ATPase activities were measured in the cerebral structures as described by Carvalho et al. 2015 . The amount of inorganic phosphate (Pi) released was quantified colorimetrically, using KH 2 PO 4 as the reference standard (Fiske and Subbarow 1927) . The absorbance was measured at 630 nm.
Determination of Ca
The specific Na + ,K + -ATPase activity was calculated by subtracting the ouabain-insensitive activity from the overall activity (in the absence of ouabain) and was expressed in nmol of Pi/min/mg of protein. Different concentrations of ouabain were used to evaluate the activity of isoforms of Na + ,K + -ATPase. For this purpose, a classical pharmacological approach was used based on the isoform-specific sensitivity to ouabain (Nishi et al. 1999) . The experiments were performed as previously described (Rambo et al. 2012) . To determine if treatments alter ouabain-sensitive ATPase activity, 3 μM or 4 mM ouabain was used (so as to only inhibit the Na + ,K + -ATPase isoforms containing subunits α2/α3, or to inhibit all isoforms, respectively).
The Ca 2+ -ATPase activity was determined by subtracting the activity measured in the presence of Ca 2+ from that determined in the absence of Ca 2+ (no added Ca 2+ plus 0.1 mM EGTA) and was expressed in nmol of Pi/min/mg of protein.
Oxidative stress parameters
Thiobarbituric acid-reactive substances (TBARS) TBARS, a measure of lipid peroxidation, was determined according to the method described by Ohkawa et al. (1979) and reported as nmol TBARS/mg of protein.
Reactive oxygen species (ROS)
ROS formation was determined according to Ali et al. (1992) . In this assay, the oxidation of dichloro-dihydro-fluorescein diacetate (DCFH-DA) to fluorescent dichlorofluorescein (DCF) was measured. DCF fluorescence intensity emission was recorded at 525 and 488 nm excitation 60 min after the addition of DCFH-DA to the medium. ROS levels were expressed as μmol DCF/mg of protein.
Nitrite assay
Nitrite concentrations were measured using the Griess reaction as described by Huang et al. 2009 . For this reaction, 50 μL of sample was reacted with 50 μL Griess reagent for 10 min at room temperature. The absorbance was measured at 540 nm using a 96-well microplate reader and the amount of nitrite in the supernatant was compared to a standard curve of known concentrations of sodium nitrate.
Total thiol content assay
This assay was performed as described by Aksenov and Markesbery (2001) . Results were reported as nmol TNB/mg of protein.
Antioxidant enzyme activities
Catalase (CAT) activity was assayed according to Aebi (1984) based on the decomposition of H 2 O 2 . Superoxide dismutase (SOD) activity was measured by the method described by Misra and Fridovich (1972) which is based on the inhibition of superoxide-dependent adrenaline auto-oxidation. Glutathione peroxidase (GPx) activity was measured using a commercially available diagnostic kit supplied by (RANSEL®; Randox Lab, Antrim, United Kingdom). Enzyme activities were reported as units/mg of protein.
Statistical analysis
Measured values were expressed as means ± S.E.M. Glucose tolerance was analyzed by repeated measures ANOVA and Bonferroni's post-hoc correction. The interaction between groups was determined by two-way ANOVA followed by Bonferroni's post-hoc test. A value of P ≤ 0.05 was considered to be statistically significant. Analyses were performed using the software GraphPad PRISM 5®.
Results
Phytochemical characterization
According to the phytochemical characterization results, the total phenolic content in PcRT was 16.72 ± 0.26 mg/g of dried extract. As to the total flavonoid content, 15.24 ± 2.09 mg/g of dried extract was detected. In addition, anthocyanin content was 2.48 ± 0.09 mg/g of dried extract. Analysis by LC/PDA/ MS/MS showed only the presence of cyanidin-3-O-glucoside in the fruit extract captured at 515 nm and with a retention time of 8.49 min. The chemical structure of anthocyanin was identified by comparison with the MS/MS data of the standard samples. The anthocyanin mass and main fragmentation figures were [M] + 449.1065 m/z (errorppm: −4.2) and 287 (m/z), respectively.
Metabolic status
As shown in Fig. 1a , HPD induced impaired glucose tolerance (P < 0.01), and treatment with PcRT prevented this change in the animals submitted to the HPD. The same profile was observed in area-under-curve (A.U.C) analysis (Fig. 1b) . Moreover, two-way ANOVA showed significant differences between the groups, suggesting that the PcRT treatment prevented the increase of some metabolic parameters such as weight gain [F(1,25) = 11.63; P < 0.01], visceral fat mass [F(1,27) = 5.18; P < 0.05], blood glucose levels [F(1,15) = 5.12; P < 0.05], total cholesterol [F(1,21) = 25.79; P < 0.001], cholesterol-LDL [F(1,13) = 92.24; P < 0.001], TAG [F(1,13) = 6.34; P < 0.05] and IL-6 [F(1,16) = 68.39; P < 0.001] caused by HPD. There were no significant differences between any of the groups tested for cholesterol-HDL, urea, uric acid, and ALT (P > 0.05) ( Table 1) .
Behavioral parameters
Two-way ANOVA showed that PcRT treatment prevented the increase in immobility time in the FST induced by consumption of HPD [F(1,23) = 10.69, P < 0.01] (Fig. 2a) . In order to rule out nonspecific motor effects that could influence activity in the FST, rats were also submitted to an openfield test (Fig. 2b) . Statistical analysis did not reveal an interaction between groups in this task [F(1,24) = 2.00 P > 0.05], suggesting that the effects of PcRT treatment in the FST are not related to changes in locomotor activity. Table 2 shows that PcRT treatment prevented the increase in the AChE activity caused by consumption of HPD in the PFC since two-way ANOVA revealed interaction between the groups [F(1,17) = 8.85, P < 0.01]. However, this enzyme activity was not altered in the HP [F(1,10) = 78.21, P > 0.05] and ST [F(1,13) = 1.53, P > 0.05].
Neurochemical parameters
With regard to ATPase activity, two-way ANOVA showed a significant interaction between experimental groups, suggesting that PcRT prevented a decrease in the activity of Ca 2+ -ATPase in PFC [F(1,12) = 12.63, P < 0.01], HP [F(1,12) = 27.48, P < 0.001] and ST [F(1,11) = 25.60, P < 0.001] induced by HPD (Fig. 3a, b and c) .
The effect of fruit extract and HPD on the total Na + ,K + -ATPase activity and its isoforms in the cerebral structures of rats is demonstrated in Fig. 4 . Two-way ANOVA revealed significant differences between the experimental groups, suggesting that the PcRT treatment prevented the decrease in total Na + ,K + -ATPase [F(1,14) = 7.85, P < 0.01]), α2,3-[F(1,12) = 9.48, P < 0.01]) and α1-isoform activities [F(1,12) = 14.93, P < 0.01] caused by HPD consumption. In HP (Fig. 4d , e, (Fig. 4g, h and i) .
Two-way ANOVA showed a significant interaction between experimental groups, suggesting the effect of PcRT administration on certain oxidative stress parameters in the cerebral structures of animals exposed to HPD. We observed that PcRT was able to prevent the increase in TBARS levels in HP [F(1,17) = 9.53, P (Table 3) .
Discussion
The berries represent a variety of small fruits characterized by purple, blue or red color and contain high levels of polyphenols, including anthocyanins, flavonoids, and other phenolic compounds (Vendrame et al. 2016 ). The PcRT is a berry belonging to the family Myrtaceae and is popularly known to demonstrate important antioxidant, anti-inflammatory, and hypoglycemic action due to the presence of bioactive compounds such as polyphenols (Inhwan et al. 2012; Ribeiro et al. 2014 ). We detected a single anthocyanin in the extract, cyanidin-3-glycoside, a widely found pigment responsible for the color of berries. This finding is relevant in a native berry from the south of Brazil since cyanidin-3-glucoside has been reported as responsible for several beneficial activities involving parameters linked to MetS (Bhaswant et al. 2015) .
In the present work, we evaluated the effects of treatment with PcRT fruit extract on metabolic, neurochemical, and behavioral parameters in animals subjected to the MetS model induced by the consumption of HPD. PcRT extract was able to prevent some of the metabolic changes induced by HPD, such as weight gain and visceral fat accumulation, glucose intolerance, hyperglycemia, and dyslipidemia. In accordance, clinical and preclinical studies have shown a reduction of glycemic index and beneficial effects in lipid metabolism by guava, belonging to Psidium genus (Batista et al. 2018; Tey et al. 2017) . It has been reported that increased TAG may cause reduction in peripheral insulin action (Khanal et al. 2012 ). In addition, it is likely that the weight gain observed in animals receiving HPD is related to increased visceral fat, since fat accumulation in this region has been reported as a determinant factor in the development of IR and MetS (Wellen and Thompson 2010; Khanal et al. 2012) . Moreover, increased visceral fat leads to increased production of proinflammatory cytokines such as tumor necrosis factor (TNF-α), interleukin1beta (IL-1β), C-reactive protein (CRP) and IL-6 (Bullo et al. 2007; Shah et al. 2008; Jayarathne et al. 2017) . We observed that HPD increased IL-6 levels and PcRT extract was able to prevent this change. Furthermore, data in the literature have demonstrated that elevated levels of IL-6 have been associated with an increased risk of diabetes, obesity and neuropsychiatric disorders (Bullo et al. 2007; Rudolf et al. 2014; Jayarathne et al. 2017) .
Bioactive compounds present in PcRT fruits such as phenolic compounds have an important effect on insulin signaling as well as on the reduction of weight, glucose, TAG, total cholesterol and LDL-cholesterol (Collins et al. 2016; Bhaswant et al. 2015; Vendrame et al. 2016) . The mechanisms underlying the actions of polyphenols present in P. cattleianum fruit extract are not well elucidated; however, some studies suggest that these compounds may inhibit digestive enzymes such as α-amylase and the absorption of glucose in the intestine (Hanhineva et al. 2010 ). Polyphenols such as quercetin and phenolic acids also act on the inhibition of sodium dependent glucose (SGLT1) and GLUT2 transporters. Inhibition of these glucose transporters could attenuate glucose level excursions after a meal (Manzano and Williamson 2010) . Furthermore, some studies have reported that cyanidin-3-glycoside may increase fatty acid oxidation through AMPactivated protein kinase (AMPK) signaling. Activation of AMPK leads to the phosphorylation and inactivation of acetyl-CoA carboxylase, increasing fatty acid oxidation, and leading to decreased visceral fat and improved glucose metabolism (Guo et al. 2010; Bhaswant et al. 2015) .
It is known that polyphenols present in the fruits of PcRT have important antioxidant and anti-inflammatory actions (Madani et al. 2015; Jayarathne et al. 2017 ). In addition, dietary interventions with compounds such as anthocyanins and flavonoids may modulate several systems that likely improve glucose homeostasis and insulin sensitivity (Bagul et al. 2012; Vendrame et al. 2016) . In this sense, we observed that the consumption of HPD increased the levels of ROS, TBARS, and nitrite levels in the brain tissues tested, and that the treatment with PcRT was able to prevent the damage caused by Table 2 Effect of P. cattleianum (red type) extract treatment in rats exposed to a highly palatable diet on acetylcholinesterase (AChE) activity in the prefrontal cortex, hippocampus and striatum HPD. We also demonstrated a reduction of thiol content in ST of animals exposed to HPD. Corroborating our findings, some data demonstrated that an increase of energy intake might lead to enhanced ROS in metabolically-active tissues such as the brain, causing lipid peroxidation and increased glucose oxidation (Madani et al. 2015; Treviño et al. 2015) . It is also known that the brain uses a significant amount of oxygen and adenosine triphosphate resulting in a high susceptibility to oxidative stress (Halliwell and Gutteridge 2007) . In addition, high nitric oxide levels, both in animals and in diabetic humans, can induce oxidative damage through the formation of peroxynitrite (Bagul et al. 2012) . We also evaluated the activity of the antioxidant enzymes SOD, CAT, and GPx and verified that the consumption of HPD was able to decrease the activity of the antioxidant enzyme SOD in all tissues studied.
However, treatment with PcRT was able to prevent this reduction. Furthermore, we observed that HPD consumption decreased the activity of the antioxidant enzyme CAT only in the ST and HP of the animals tested. In contrast, treatment with PcRT extract prevented the decrease in the activity of this enzyme only in the HP of the animals tested. Data in the literature also demonstrate a significant decrease in antioxidant enzymes such as SOD and CAT in brain tissues such as PFC, HP, and ST of animals fed HPD (Treviño et al. 2015; Oliveira et al. 2017a; Oliveira et al. 2017b) .
Recently, it has been suggested that MetS may cause neuropsychiatric complications such as depression, since chronic hyperglycemia and IR can trigger an inflammatory state and oxidative stress inducing neurotransmitter oxidation, neuroinflammation and neural death (Farooqui et al. 2012; Treviño et al. 2015; Oliveira et al. 2017a, b; Gancheva et al. 2017) . Hence, we evaluated the depressive-like behavior of animals that received HPD and observed that the consumption of this diet increased the immobility time in the FST indicating a depressive-like behavior. However, treatment with PcRT extract prevented this alteration. Corroborating our findings, some studies have demonstrated an antidepressant-like effect of certain berries (Kumar et al. 2012; Oliveira et al. 2017a, b) . In addition, Gancheva et al. (2017) also demonstrated an increase in the time of immobility in FST of animals submitted to a diet enriched with saturated fat and fructose, indicating a depressive-like behavior, which in turn correlated with the metabolic effect of diet, especially with lipid peroxidation. Moreover, it has been suggested that the increase in the production of pro-inflammatory cytokines mainly produced by visceral adipose tissue has shown a positive correlation between obesity and neuropsychiatric disorders (Ambrósio et al. 2018) . In fact, in our study we observed an increase in serum levels of IL-6 in animals submitted to HPD.
In an attempt to clarify the behavioral changes found in our study, we evaluated the influence of HPD and PcRT on the activity of Na + ,K + -ATPase and its α1, α2, and α3 isoforms in the PFC, HP, and ST. Thus, we observed that the consumption of HPD significantly decreased the activity of this enzyme in PFC and HP and that the treatment with PcRT was able to restore enzyme activity. Corroborating our findings, Gamaro et al. (2003) and Quines et al. (2016) have also demonstrated an association between the reduction of Na + ,K + -ATPase and the increase of FST immobility time in animals submitted to a model of depression, reinforcing the hypothesis that changes in the activity of this enzyme may be related to behavioral alterations. Besides, Na + ,K + -ATPase is responsible for maintaining the cellular electrochemical balance, which is fundamental in the differentiation of the nervous system. However, a decrease in its catalytic activity directly compromises neural function (Carvalho et al. 2015; Quines et al. 2016) . Ca 2+ -ATPase is also an important enzyme and plays a role in maintaining electrolyte balance in all mammals. This 2+ since its accumulation can damage the cell (Carvalho et al. 2015) . In this regard, we observed that the consumption of HPD decreased enzymatic activity in all tissues tested. On the other hand, treatment with PcRT prevented this decrease. The neuroprotective effect of the PcRT extract may be related to its antioxidant activity, since these enzymes are involved in the maintenance of the ionic gradient across the cell membrane and, therefore, its inhibition can be attributed to cell membrane lipoperoxidation and ROS increase, which may lead to the oxidation of groups essential for enzymatic activity (Sharma et al. 2009; Carvalho et al. 2015; Srikanthan et al. 2016) . Carvalho et al. (2015) also related the decrease in Ca 2+ -ATPase and Na + ,K + -ATPase activity to the increase of oxidative stress markers. Data in the literature have demonstrated significant increases in AChE activity in brain structures of animals with metabolic diseases and dysfunctions in the central nervous system (Zarros et al. 2009; Liapi et al. 2010; Oliveira et al. 2017b) . We can speculate that the increase in this enzyme activity observed in PFC of the animals exposed to HPD may be related to a disturbance in Ca 2+ homeostasis, since the influx of this ion leads to an increase in ROS production and, consequently, lipid peroxidation, which can cause a change in the conformational state of the enzyme (Melo et al. 2003) . This fact would also explain the prevention of increased AChE activity by treatment with PcRT extract which has shown antioxidant effects.
In summary, our findings demonstrate that treatment with PcRT extract prevented the development of MetS induced by HPD, since it improved the body composition and demonstrated anti-hyperglycemic and anti-hyperlipidemic effects. In addition, the extract prevented the development of behavioral and neurochemical changes observed in this pathology. Thus, we can suggest that PcRT extract has neuroprotective properties, proving to be a potential therapeutic agent for individuals with MetS (Fig. 5) . 
